# Cellective BioTherapy, Inc. — Form D

Cellective BioTherapy, Inc. of RESEARCH TRIANGLE PARK, NC, a company, filed a Form D exempt-offering notice with the SEC on 2015-05-28. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2015-05-28
- Form: D
- Accession: 0001643495-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 2
- Date of first sale: 2015-05-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-240663

## Issuer

- Name: Cellective BioTherapy, Inc.
- CIK: 0001643495
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 6 DAVIS DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Phone: 919-684-3681

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Robert F Bonczek | Director | Research Triangle Park, NC |
| Thomas F Tedder | Director | Research Triangle Park, NC |
| Robert F Bonczek | Executive Officer | Research Triangle Park, NC |
| Thomas F Tedder | Executive Officer | Research Triangle Park, NC |
| Robert F Bonczek | Promoter | Research Triangle Park, NC |
| Thomas F Tedder | Promoter | Research Triangle Park, NC |

## More

- [CIK 1643495 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1643495&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001643495-15-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.